InsiderClue
Insiders · Profile

Schmid John P.

Director at BlossomHill Therapeutics · Director at ANAPTYSBIO · Director at Xeris Biopharma · and 1 more. Filing since 16 Nov 2023. CIK 0001478916

BLSM BlossomHill Therapeutics, Inc. Director · 1 trade ANAB ANAPTYSBIO, INC Director · 1 trade XERS Xeris Biopharma Holdings, Inc. Director · 5 trades DSGN Design Therapeutics, Inc. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
BLSM BlossomHill Therapeutics, Inc.
10 Aug 2026
Director
Bought
6,000
$96.00K
opened
ANAB ANAPTYSBIO, INC
30 Mar 2026
Director
Sold at will
20,645
$1.16M
39.5%
XERS Xeris Biopharma Holdings, Inc.
12 Aug 2024
Director
Bought
4,515
$10.15K
21.8%
XERS Xeris Biopharma Holdings, Inc.
9 Aug 2024
Director
Bought
4,285
$10.13K
26.1%
XERS Xeris Biopharma Holdings, Inc.
10 May 2024
Director
Bought
5,400
$10.31K
49.1%
DSGN Design Therapeutics, Inc.
25 Mar 2024
Director
Bought
17,809
$66.61K
195%
DSGN Design Therapeutics, Inc.
22 Mar 2024
Director
Bought
9,156
$33.13K
opened
XERS Xeris Biopharma Holdings, Inc.
14 Mar 2024
Director
Bought
4,500
$9.72K
69.2%
XERS Xeris Biopharma Holdings, Inc.
16 Nov 2023
Director
Bought
6,500
$9.82K
opened
9 decisions on file.